The Bottom Line
Polycystic ovary syndrome (PCOS) is the most common cause of androgen-related hair loss in premenopausal women, affecting approximately 5-10% of women of reproductive age. Excess androgens (testosterone and DHEA-S) cause hair follicles on the scalp to miniaturize while simultaneously promoting unwanted hair growth on the face and body. Treatment targets both the hormonal imbalance and the hair follicles directly.
How PCOS Causes Hair Loss
In PCOS, the ovaries (and sometimes the adrenal glands) produce elevated levels of androgens, particularly testosterone and its more potent derivative, DHT. These androgens affect hair in two opposite ways:
- On the scalp: DHT binds to androgen receptors in genetically susceptible hair follicles, causing them to progressively miniaturize — producing thinner, shorter, less pigmented hairs until they produce only vellus (peach fuzz) hair
- On the body/face: The same androgens stimulate vellus hairs to convert to terminal (thick, dark) hairs, causing hirsutism (unwanted facial and body hair)
This paradoxical response — losing hair where you want it and gaining it where you don't — is one of the most distressing aspects of PCOS.
Pattern of PCOS Hair Loss
PCOS-related hair loss typically presents as:
- Diffuse thinning across the top and crown of the scalp
- Widening of the central part
- Preserved frontal hairline (like female pattern hair loss)
- In more severe cases, thinning may extend to the temporal (side) areas, which is more typical of androgen-excess hair loss than idiopathic female pattern hair loss
- Often accompanied by acne and hirsutism
Treatment Strategy
Effective treatment addresses both the hormonal cause and the follicular effects:
Anti-androgen therapy (addresses the cause):
- Spironolactone (100-200mg daily): The most commonly prescribed anti-androgen for PCOS hair loss. Blocks androgen receptors and reduces adrenal androgen production. Takes 6-12 months for visible improvement. Must use contraception (teratogenic).
- Combined oral contraceptives: Pills with anti-androgenic progestins (drospirenone, cyproterone acetate) suppress ovarian androgen production and raise SHBG. Often used in combination with spironolactone.
- Metformin: Improves insulin resistance in PCOS, which in turn reduces ovarian androgen production. May modestly help hair when insulin resistance is a driver.
Direct follicle stimulation:
- Minoxidil 5% topical: Apply once daily to stimulate existing follicles. Works independently of hormones. Produces visible results in 4-6 months.
- Oral minoxidil (0.25-2.5mg): Off-label option for women who don't tolerate topical application
Lifestyle modifications (address insulin resistance):
- Weight management: even 5-10% weight loss in overweight women can significantly reduce androgen levels
- Low-glycemic diet: reduces insulin, which drives ovarian androgen production
- Regular exercise: improves insulin sensitivity
Frequently Asked Questions
Will treating PCOS reverse my hair loss?
Treatment can stabilize hair loss and promote partial regrowth, but complete restoration to pre-PCOS hair density may not be achievable if significant miniaturization has occurred. The earlier treatment starts, the better the outcome — it's easier to maintain existing hair than to regrow lost hair.
How is PCOS hair loss different from normal female pattern hair loss?
The hair loss pattern may look identical. The difference is the underlying cause — PCOS involves measurably elevated androgens, while some women with female pattern hair loss have normal androgen levels but genetically sensitive follicles. PCOS hair loss often presents with additional signs: acne, hirsutism, irregular periods, and insulin resistance.
Can natural supplements help PCOS hair loss?
Some supplements show modest evidence: inositol (myo-inositol 2-4g daily) improves insulin resistance and may help hormonal balance; zinc (30mg daily) has mild anti-androgen effects; saw palmetto may modestly inhibit 5-alpha reductase. However, these are adjuncts, not replacements, for proven medical therapy.
- Azziz R, et al. "Polycystic ovary syndrome." Nature Reviews Disease Primers. 2016;2:16057.
- Sinclair R, et al. "Treatment of female pattern hair loss with oral antiandrogens." British Journal of Dermatology. 2005;152(3):466-473.
- Quinn M, et al. "Prevalence of androgenic alopecia in patients with polycystic ovary syndrome." Human Reproduction. 2014;29(10):2190-2194.